triptolide has been researched along with Cancer of Mouth in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YW; Kuo, CS; Lin, CK; Lin, GJ; Sytwu, HK; Yang, CY | 1 |
Das Majumdar, SK; Dash, R; Maji, S; Muduly, DK; Panda, S; Priyadarshini, M; Rath, R; Samal, SK; Shriwas, O | 1 |
Chang, WC; Chen, YT; Chen, YW; Hsieh, CC; Lin, CK; Lin, CS; Lin, GJ; Peng, B; Sytwu, HK; Ting, CC; Tsao, CH; Yang, CY | 1 |
Li, J; Li, JD; Liang, RY; Pei, LJ; Xin, ZQ; Zhao, ZH | 1 |
Chen, YW; Chia, WT; Chuang, YP; Lin, CK; Lin, GJ; Sytwu, HK | 1 |
5 other study(ies) available for triptolide and Cancer of Mouth
Article | Year |
---|---|
Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-γ-modulated microenvironment in vitro, in vivo, and in clinical patients.
Topics: Adult; Aged; Aged, 80 and over; Animals; B7-H1 Antigen; Cell Line, Tumor; Cell Proliferation; Diterpenes; Down-Regulation; Epoxy Compounds; Female; Humans; Immune Checkpoint Inhibitors; Interferon-gamma; Janus Kinase 2; Male; Mice, Inbred NOD; Mice, SCID; Middle Aged; Mouth Neoplasms; Phenanthrenes; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; STAT1 Transcription Factor; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2021 |
STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cisplatin; Diterpenes; Drug Resistance, Neoplasm; Epoxy Compounds; Fluorouracil; Glycogen Synthase Kinase 3 beta; Humans; Male; Mice; Mouth Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Phenanthrenes; Proto-Oncogene Proteins c-akt; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor; Taxoids | 2019 |
Anti-oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient-derived tumor xenograft model.
Topics: Animals; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Proliferation; Diterpenes; Down-Regulation; Epoxy Compounds; Heterografts; Humans; Immunohistochemistry; Mice; Mice, Inbred NOD; Mouth Neoplasms; Phenanthrenes; Receptors, Tumor Necrosis Factor, Member 6b; Xenograft Model Antitumor Assays | 2019 |
[Effect of triptolide on human oral cancer cell proliferation and PTEN gene mRNA expression in oral cancer].
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Proliferation; Diterpenes; Epoxy Compounds; Humans; Mouth Neoplasms; Phenanthrenes; PTEN Phosphohydrolase; RNA, Messenger; Time Factors | 2017 |
Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Disease Models, Animal; Diterpenes; Drug Screening Assays, Antitumor; Epoxy Compounds; Humans; KB Cells; Mice; Mice, Inbred NOD; Mice, SCID; Mouth Neoplasms; Phenanthrenes | 2009 |